Doctor profile · Federal record
Dr. Omar Al Ustwani, MD
Internal Medicine Physician (CMS: Hematology/Oncology) · Vineland, NJ
- NPI 1275769978
- Accepts Medicare
- 19 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1505 W. Sherman Avenue, Suite 101
Vineland, NJ 08360
(856) 696-9550
fax (856) 691-1686 - Mailing address
-
Elm and Carlton St
Buffalo, NY 142630001
Credentials & registration
- NPI registered
- June 2009 — 17 yrs on file
- Profile last updated
- November 15, 2016
- Year of graduation
- 2007 — 19 yrs since
- Specialty taxonomy
- 207R00000X — NUCC code
- State license (1)
- New Jersey #25MA08952200
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1275769978. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
69,258
Distinct HCPCS
10
Medicare allowed
$848,801
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 38,250 | 39 | $1 | |
J9271 |
Injection, pembrolizumab, 1 mg | 8,800 | 15 | $54 | |
J1453 |
Injection, fosaprepitant, 1 mg | 3,900 | 18 | $0 | |
J1756 |
Injection, iron sucrose, 1 mg | 3,600 | 13 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 3,480 | 19 | $23 | |
J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units | 2,900 | 28 | $8 | |
Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 1,980 | 22 | $8 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,164 | 49 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 900 | 38 | $1 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 737 | 304 | $8 |
In context: peer comparison
Among 12 peers in this city , average services per provider: 478. This provider delivers 145× the peer median.Open Payments
Industry payments received
All-time total
$1,261
Transactions
53
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| PFIZER INC. | 9 | $156.66 | |
| Novartis Pharmaceuticals Corporation | 8 | $147.77 | |
| AstraZeneca Pharmaceuticals LP | 8 | $128.88 | |
| E.R. Squibb & Sons, L.L.C. | 5 | $84.89 | |
| Adaptive Biotechnologies Corporation | 1 | $64.58 | |
| Merck Sharp & Dohme LLC | 3 | $53.61 | |
| Daiichi Sankyo Inc. | 2 | $38.01 | |
| Kite Pharma, Inc. | 2 | $37.69 | |
| ARRAY BIOPHARMA INC | 3 | $36.48 | |
| SOBI, INC | 2 | $35.62 | |
| Stemline Therapeutics Inc. | 2 | $34.34 | |
| Celgene Corporation | 2 | $33.15 | |
| BeiGene USA, Inc. | 2 | $32.50 | |
| GENZYME CORPORATION | 2 | $32.45 | |
| Janssen Biotech, Inc. | 2 | $30.57 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
746
Patients
221
Total drug cost
$1,008,372
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 139 | 32 | $97,173 |
| Anastrozole | Generic | 117 | 28 | $2,826 |
| Oxycodone Hcl | Generic | 56 | 23 | $1,779 |
| Pantoprazole Sodium | Generic | 51 | 19 | $453 |
| Xarelto (Rivaroxaban) | Brand | 49 | 15 | $53,948 |
| Letrozole | Generic | 48 | 17 | $1,821 |
| Procrit (Epoetin Alfa) | Brand | 40 | 13 | $89,750 |
| Mirtazapine | Generic | 38 | 16 | $451 |
| Revlimid (Lenalidomide) | Brand | 38 | 12 | $735,952 |
| Prednisone | Generic | 34 | 11 | $399 |
Hospital affiliations
Frequently asked questions
What is Dr. Omar Al Ustwani's medical specialty?
Dr. Omar Al Ustwani practices Internal Medicine Physician in Vineland, NJ.
Where does Dr. Omar Al Ustwani practice?
Dr. Omar Al Ustwani practices at 1505 W. Sherman Avenue, Vineland, NJ 08360. Office phone: 8566969550.
What is Dr. Omar Al Ustwani's NPI?
Dr. Omar Al Ustwani's National Provider Identifier (NPI) is 1275769978, issued by NPPES.
Does Dr. Omar Al Ustwani accept Medicare assignment?
Yes. Dr. Omar Al Ustwani accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Omar Al Ustwani commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, fosaprepitant, 1 mg (HCPCS J1453). Source: CMS Medicare Physician & Other Practitioners file.